First Squawk(@FirstSquawk):ASTRAZENECA- TOZORAKIMAB SHOWS STATISTICALLY SIGNIFICANT,CLINICALLY MEANINGFUL REDUCTION IN COPD EXACERBATIONS IN OBERON, TITANIA PHASE III TRIALS || ASTRAZENECA- TOZORAKIMAB 300MG SHOWS REDUCTION IN MODERATE, SEVERE COPD EXACERBATIONS IN OVERALL CURRENT, FORMER SMOKER POPULATION BY 30% IN OBERON

First Squawk

@FirstSquawk

Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics

Joined July 2015

251 Following 569.3K Followers

First Squawk@FirstSquawk

2026.09.08 11:47

ASTRAZENECA- TOZORAKIMAB SHOWS STATISTICALLY SIGNIFICANT,CLINICALLY MEANINGFUL REDUCTION IN COPD EXACERBATIONS IN OBERON, TITANIA PHASE III TRIALS || ASTRAZENECA- TOZORAKIMAB 300MG SHOWS REDUCTION IN MODERATE, SEVERE COPD EXACERBATIONS IN OVERALL CURRENT, FORMER SMOKER POPULATION BY 30% IN OBERON